Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus, Type 2 × Diet × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 13 Breast Neoplasms 10 Polycystic Ovary Syndrome 8 Obesity 8 Colorectal Neoplasms 6 Weight Loss 5 Prostatic Neoplasms 5 Neoplasms 4 Colonic Neoplasms 4 Multiple Endocrine Neoplasia Type 1 3 Endometrial Neoplasms 3 Pancreatic Neoplasms 2 Overweight 2 Malnutrition 2 Lymphoma, Follicular 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Waldenstrom Macroglobulinemia 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Smoking 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Compliance 1

Interventions

relacorilant 5 Pioglitazone 4 Metformin 4 Sitagliptin Phosphate 3 saxagliptin 2 Vildagliptin 2 Sulfonylurea Compounds 2 Rosiglitazone 2 Resistance Training 2 Nutritional Status 2 Dipeptidyl-Peptidase IV Inhibitors 2 Blood Specimen Collection 2 voglibose 1 somapacitan 1 semaglutide 1 repaglinide 1 pembrolizumab 1 miglitol 1 metahexamide 1 meglitinide 1 mazdutide 1 glymidine 1 glisoxepide 1 gliquidone 1 glimepiride 1 glibornuride 1 dapagliflozin 1 alogliptin 1 Urine Specimen Collection 1 Troglitazone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03206827 2021-09-27

ScenoProt

University of Helsinki

Phase NA Completed

Gastrointestinal

Diabetes Mellitus, Type 2, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡